Antifungal Agents Market Trends, Size, Competitive Analysis and Forecast 2018-2023
Global antifungal agents market is expected to grow at a moderate rate during the forecast period. This market includes drugs, powder, ointments, and pastes that are used to treat fungal infections. These antifungal agents prevent and destroy the growth of fungi that are responsible for various diseases such as aspergillosis, ringworm, skin infection and so forth. The antifungal drugs include azoles, polyenes, Echinocandins and allylamines. These drugs are widely used for the treatment of several fungal infections such as candidiasis, ringworm and tinea pedis. Increasing funding programs for the development of antifungal agents support in the effective treatment of fungal diseases. For instance, in June 2016, the Department of Molecular Genetics & Microbiology, Stony Brook University received a grant valued over $6.0 million from the National Institute of Health (NIH). This grant was intended to discover new approaches for the treatment of fungal infections based on collaborative and laboratory research along with experts, globally. They will collaborate for the development of the new class of antifungal agents. According to the experts, systemic fungal infections cause over one million fatalities each year. In addition, the treatment of such conditions is generally not effective coupled with drug resistance or toxicity. Thus, the funding from NIH enables recognizing the widespread requirement for potential antifungal treatments. As a result, it enables to drive the growth of the global antifungal agents market.
To Request a Sample of our Report on Antifungal Agents Market: https://www.omrglobal.com/request-sample/antifungal-agents-market
Moreover, other factors that are contributing towards the growth of
antifungal agents market include rising incidence and prevalence of fungal
diseases, advances in antifungal agents and increasing demand for azole class
of drugs. However, adverse effects associated with antifungal drugs and
stringent government regulations are creating hurdles in the market growth. The
market is offering significant growth opportunities due to improving healthcare
infrastructure and growing awareness about fungal infections. The global
antifungal agents market has been segmented on the basis of application,
drug-class, type and route of administration. According to drug-class, the
market is further classified into polyenes, echinocandins, allylamines, azoles
and others (flucytosine, griseofulvin and tolnaftate). Azoles class of drugs is
gaining a significant position as it is one of the most preferred options for
the treatment of systemic fungal infections. Based on the type, the market is
classified into powders, ointments, drugs and pastes. According to the route of
administration, the market is further classified into parenteral, topical and
oral. Topical antifungals are considered as an essential adjuvant to treat
dermatophytoses. Moreover, in certain conditions, including dermatophytoses in
infants and pregnancy usually warrant topic therapy. This enables to drive the
demand for topical antifungals.
A
full Report Antifungal Agents Market is
Available at: https://www.omrglobal.com/industry-reports/antifungal-agents-market
·
Polyene
·
Echinocandins
·
Allylamines
·
Azole
By dosage
type
·
Powders
·
Ointments
·
Drugs
·
Paste
By Route of Administration
·
Parenteral
·
Topical
·
Oral
Competitive
Landscape
·
Key
Company Analysis
·
Key
Strategy Analysis
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Abbott
Laboratories, Inc.
·
Amplyx
Pharmaceuticals, Inc.
·
Astellas
Pharma, Inc.
·
Basilea
Pharmaceutica AG
·
Bayer
Healthcare LLC
·
Bristol-Myers
Squibb Pharmaceuticals, Ltd.
·
Cosmo
Pharmaceuticals NV
·
Gilead
Sciences, Inc.
·
Janssen
Pharmaceutica NV
·
Mayne
Pharma, Inc.
·
Merck
& Co., Inc.
·
Mylan
Pharmaceuticals, Inc.
·
Nouvasant
Pharmhealth Ltd.
·
Pfizer,
Inc.
·
Sanofi-Aventis
U.S. LLC
·
Scynexis,
Inc.
·
Sumitomo
Dainippon Pharma Co., Ltd.
·
Sun
Pharmaceutical Industries, Ltd.
·
Teva
Pharmaceutical Industries, Ltd.
·
Zydus
Cadila Healthcare Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antifungal-agents-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment